Share on StockTwits

Nu Skin Enterprises (NYSE:NUS) was downgraded by research analysts at Bank of America to an “underperform” rating in a report released on Friday.

Several other analysts have also recently commented on the stock. Analysts at Ned Davis Research upgraded shares of Nu Skin Enterprises from a “neutral” rating to a “buy” rating in a research note on Monday, May 12th. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Nu Skin Enterprises in a research note on Wednesday, May 7th. They now have a $100.00 price target on the stock, down previously from $115.00. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company’s stock. Nu Skin Enterprises presently has an average rating of “Hold” and an average price target of $109.97.

Shares of Nu Skin Enterprises (NYSE:NUS) opened at 66.51 on Friday. Nu Skin Enterprises has a 52 week low of $66.36 and a 52 week high of $140.50. The stock has a 50-day moving average of $73.35 and a 200-day moving average of $83.06. The company has a market cap of $3.921 billion and a price-to-earnings ratio of 11.18.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $1.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.11. The company had revenue of $671.10 million for the quarter, compared to the consensus estimate of $656.82 million. During the same quarter in the previous year, the company posted $0.90 earnings per share. The company’s revenue for the quarter was up 24.0% on a year-over-year basis. On average, analysts predict that Nu Skin Enterprises will post $6.01 earnings per share for the current fiscal year.

Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.